211 related articles for article (PubMed ID: 29154208)
1. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
[TBL] [Abstract][Full Text] [Related]
2. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
[TBL] [Abstract][Full Text] [Related]
3. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
5. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
Front Immunol; 2021; 12():665541. PubMed ID: 33986753
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
Leuk Res; 2009 Apr; 33(4):539-46. PubMed ID: 18845337
[TBL] [Abstract][Full Text] [Related]
8. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
9. Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.
Müller-Schmah C; Solari L; Weis R; Pfeifer D; Scheibenbogen C; Trepel M; May AM; Engelhardt R; Lübbert M
Ann Hematol; 2012 Jan; 91(1):27-32. PubMed ID: 21959947
[TBL] [Abstract][Full Text] [Related]
10. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine.
Li Y; Yang F; Sang L; Zhu J; Han X; Shan F; Li S; Zhai J; Wang D; Lu C; Sun X
Oncol Rep; 2015 Oct; 34(4):1795-804. PubMed ID: 26238268
[TBL] [Abstract][Full Text] [Related]
12. CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells.
Baessler T; Charton JE; Schmiedel BJ; Grünebach F; Krusch M; Wacker A; Rammensee HG; Salih HR
Blood; 2010 Apr; 115(15):3058-69. PubMed ID: 20008791
[TBL] [Abstract][Full Text] [Related]
13. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
14. Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
Müller LME; Migneco G; Scott GB; Down J; King S; Askar B; Jennings V; Oyajobi B; Scott K; West E; Ralph C; Samson A; Ilett EJ; Muthana M; Coffey M; Melcher A; Parrish C; Cook G; Lawson M; Errington-Mais F
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741729
[TBL] [Abstract][Full Text] [Related]
15. The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro.
Vasold J; Wagner M; Drolle H; Deniffel C; Kütt A; Oostendorp R; Sironi S; Rieger C; Fiegl M
Leuk Res; 2015 Feb; 39(2):257-62. PubMed ID: 25542695
[TBL] [Abstract][Full Text] [Related]
16. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
[TBL] [Abstract][Full Text] [Related]
18. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
Front Immunol; 2021; 12():730970. PubMed ID: 34975835
[TBL] [Abstract][Full Text] [Related]
19. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
[TBL] [Abstract][Full Text] [Related]
20. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]